What is SDI Diagnostics?
Established in 1978, SDI Diagnostics has carved out a specialized niche in the development and distribution of high-quality spirometry equipment and essential respiratory supplies. By maintaining a robust manufacturing footprint within the United States and ensuring strict adherence to FDA regulatory standards, the company provides healthcare institutions with reliable, precision-engineered diagnostic tools. Their product portfolio, which includes a diverse range of spirometers and compatible filters, is supported by a legacy of technical expertise and dedicated customer service, positioning them as a trusted partner for clinical providers seeking accurate pulmonary assessment solutions.
How much funding has SDI Diagnostics raised?
SDI Diagnostics has raised a total of $353K across 1 funding round:
Debt
$353K
Debt (2021): $353K with participation from PPP
Key Investors in SDI Diagnostics
PPP
Public-Private Partnership
What's next for SDI Diagnostics?
The recent influx of capital is expected to catalyze the next phase of the company's growth trajectory, likely focusing on the modernization of its diagnostic hardware and the expansion of its distribution networks. As the healthcare sector increasingly prioritizes remote monitoring and high-fidelity respiratory data, SDI Diagnostics is well-positioned to leverage its established reputation to capture additional market share. Future strategic initiatives will likely involve enhancing product integration capabilities and scaling operations to meet the rising global demand for efficient, compliant respiratory diagnostic technology, ensuring the firm remains at the forefront of clinical pulmonary care.
See full SDI Diagnostics company page
